"The benefit that really Alcimed brought to the table was to have an expert intermediary to take us through the process to really challenge our thinking."

Mark Twyman, Senior VP and Chief Commercial Officer at Inovio

Inovio Pharmaceuticals and Alcimed co-built a structured decision-making process to evaluate and prioritize therapeutic candidates in clinical development, drawing on a benchmark of industry best practices.

"The Alcimed team has allowed us to structure the project appropriately, to plan it in the best possible way, and to make sure that every single step of the project was successful."

Federico Bianco, Head of the Special Care Unit at Chiesi

Chiesi and Alcimed collaborated to assess the care pathway of preterm infants at higher risk of developing chronic respiratory infections later in life.

"Together between Alcimed and Nestlé Health Science, we made informed decision on where the best opportunities were and why and how to select the most valuable assets in our investigation."

Bernard Cuenoud, Global Head of Research and Clinical Development at Nestlé Health Science

Nestlé Health Science and Alcimed conducted a state-of-the-art review and a mapping study of rare diseases and associated preclinical and clinical research projects, with a focus on metabolism and nutrition, to identify, assess, and prioritize the most promising development opportunities.